Eli Lilly's head of obesity talks weight-loss innovations for 2025 — from an Ozempic-like pill to a triple-threat shot
Eli Lilly's Ozempic-rivaling weight-loss pill orforglipron could be available in early 2026. Its retatrutide may be as ...
Business Insider7d
Eli Lilly & Co (LLY) Receives a Buy from Bank of America Securities
Anderson covers the Healthcare sector, focusing on stocks such as Eli Lilly & Co, Johnson & Johnson, and Pfizer. Currently, the analyst consensus on Eli Lilly & Co is a Strong Buy with an average ...